CNO Financial Group, Inc. 5.125 (CNO-PA) Stock Competitors & Peer Comparison
See (CNO-PA) competitors and their performances in Stock Market.
Peer Comparison Table: Insurance - Diversified Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNO-PA | $17.05 | +0.00% | 4.6B | N/A | N/A | +1.40% |
| BRK-B | $489.48 | +0.51% | 1.1T | 14.52 | $33.58 | N/A |
| BRK-A | $734,500.00 | +1.08% | 1.1T | 14.50 | $50,394.88 | N/A |
| AIG-PA | $62.68 | +6.02% | 112.5B | 5.48 | $11.44 | +2.43% |
| AEH | $25.67 | +0.00% | 52.5B | 19.37 | $1.33 | +5.28% |
| AED | $25.52 | +0.00% | 52.2B | 19.26 | $1.33 | +5.28% |
| AEB | $25.01 | -0.08% | 51.1B | 18.88 | $1.33 | +5.28% |
| SLF | $74.36 | +1.14% | 41B | 19.15 | $3.86 | +3.59% |
| AIG | $74.08 | -0.03% | 39.2B | 13.01 | $5.68 | +2.43% |
| ACGL | $90.94 | +1.48% | 31.6B | 6.95 | $13.00 | N/A |
Stock Comparison
CNO-PA vs BRK-B Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, BRK-B has a market cap of 1.1T. Regarding current trading prices, CNO-PA is priced at $17.05, while BRK-B trades at $489.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-B's P/E ratio is 14.52. In terms of profitability, CNO-PA's ROE is +0.10%, compared to BRK-B's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to BRK-B. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check BRK-B's competition here
CNO-PA vs BRK-A Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, BRK-A has a market cap of 1.1T. Regarding current trading prices, CNO-PA is priced at $17.05, while BRK-A trades at $734,500.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-A's P/E ratio is 14.50. In terms of profitability, CNO-PA's ROE is +0.10%, compared to BRK-A's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to BRK-A. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check BRK-A's competition here
CNO-PA vs AIG-PA Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AIG-PA has a market cap of 112.5B. Regarding current trading prices, CNO-PA is priced at $17.05, while AIG-PA trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG-PA's P/E ratio is 5.48. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AIG-PA's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to AIG-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIG-PA's competition here
CNO-PA vs AEH Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AEH has a market cap of 52.5B. Regarding current trading prices, CNO-PA is priced at $17.05, while AEH trades at $25.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEH's P/E ratio is 19.37. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AEH's ROE of +0.12%. Regarding short-term risk, CNO-PA is less volatile compared to AEH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AEH's competition here
CNO-PA vs AED Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AED has a market cap of 52.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while AED trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AED's P/E ratio is 19.26. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AED's ROE of +0.12%. Regarding short-term risk, CNO-PA is less volatile compared to AED. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AED's competition here
CNO-PA vs AEB Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AEB has a market cap of 51.1B. Regarding current trading prices, CNO-PA is priced at $17.05, while AEB trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEB's P/E ratio is 18.88. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AEB's ROE of +0.12%. Regarding short-term risk, CNO-PA is less volatile compared to AEB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AEB's competition here
CNO-PA vs SLF Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, SLF has a market cap of 41B. Regarding current trading prices, CNO-PA is priced at $17.05, while SLF trades at $74.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas SLF's P/E ratio is 19.15. In terms of profitability, CNO-PA's ROE is +0.10%, compared to SLF's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to SLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check SLF's competition here
CNO-PA vs AIG Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AIG has a market cap of 39.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while AIG trades at $74.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG's P/E ratio is 13.01. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AIG's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to AIG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIG's competition here
CNO-PA vs ACGL Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ACGL has a market cap of 31.6B. Regarding current trading prices, CNO-PA is priced at $17.05, while ACGL trades at $90.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGL's P/E ratio is 6.95. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ACGL's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ACGL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGL's competition here
CNO-PA vs ATH Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH has a market cap of 19.8B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH trades at $83.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH's P/E ratio is 4.42. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH's competition here
CNO-PA vs ACGLP Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ACGLP has a market cap of 15.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while ACGLP trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLP's P/E ratio is 5.03. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ACGLP's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGLP's competition here
CNO-PA vs BNT Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, BNT has a market cap of 15.1B. Regarding current trading prices, CNO-PA is priced at $17.05, while BNT trades at $45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BNT's P/E ratio is 16.61. In terms of profitability, CNO-PA's ROE is +0.10%, compared to BNT's ROE of +0.03%. Regarding short-term risk, CNO-PA is less volatile compared to BNT. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check BNT's competition here
CNO-PA vs AEG Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AEG has a market cap of 12.6B. Regarding current trading prices, CNO-PA is priced at $17.05, while AEG trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEG's P/E ratio is 11.89. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AEG's ROE of +0.12%. Regarding short-term risk, CNO-PA is less volatile compared to AEG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AEG's competition here
CNO-PA vs EQH Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, EQH has a market cap of 11.8B. Regarding current trading prices, CNO-PA is priced at $17.05, while EQH trades at $42.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH's P/E ratio is -14.71. In terms of profitability, CNO-PA's ROE is +0.10%, compared to EQH's ROE of -2.20%. Regarding short-term risk, CNO-PA is less volatile compared to EQH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check EQH's competition here
CNO-PA vs ACGLO Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ACGLO has a market cap of 11.3B. Regarding current trading prices, CNO-PA is priced at $17.05, while ACGLO trades at $19.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLO's P/E ratio is 4.13. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ACGLO's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGLO's competition here
CNO-PA vs ORI Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ORI has a market cap of 9.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while ORI trades at $38.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ORI's P/E ratio is 9.33. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ORI's ROE of +0.17%. Regarding short-term risk, CNO-PA is less volatile compared to ORI. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ORI's competition here
CNO-PA vs ACGLN Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ACGLN has a market cap of 5.9B. Regarding current trading prices, CNO-PA is priced at $17.05, while ACGLN trades at $16.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLN's P/E ratio is 3.45. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ACGLN's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLN. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ACGLN's competition here
CNO-PA vs EQH-PA Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, EQH-PA has a market cap of 5.6B. Regarding current trading prices, CNO-PA is priced at $17.05, while EQH-PA trades at $19.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PA's P/E ratio is 5.09. In terms of profitability, CNO-PA's ROE is +0.10%, compared to EQH-PA's ROE of -2.20%. Regarding short-term risk, CNO-PA is less volatile compared to EQH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check EQH-PA's competition here
CNO-PA vs ESGRP Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ESGRP has a market cap of 5.3B. Regarding current trading prices, CNO-PA is priced at $17.05, while ESGRP trades at $20.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRP's P/E ratio is -13.72. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ESGRP's ROE of +0.03%. Regarding short-term risk, CNO-PA and ESGRP have similar daily volatility (0.00).Check ESGRP's competition here
CNO-PA vs ATH-PE Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH-PE has a market cap of 5.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH-PE trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PE's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH-PE's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PE. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PE's competition here
CNO-PA vs ATH-PC Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH-PC has a market cap of 5.1B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH-PC trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PC's P/E ratio is 3.14. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH-PC's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PC's competition here
CNO-PA vs ESGR Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ESGR has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.05, while ESGR trades at $337.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGR's P/E ratio is 10.83. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ESGR's ROE of +0.03%. Regarding short-term risk, CNO-PA and ESGR have similar daily volatility (0.00).Check ESGR's competition here
CNO-PA vs ESGRO Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ESGRO has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.05, while ESGRO trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRO's P/E ratio is -12.87. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ESGRO's ROE of +0.03%. Regarding short-term risk, CNO-PA and ESGRO have similar daily volatility (0.00).Check ESGRO's competition here
CNO-PA vs UNMA Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, UNMA has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.05, while UNMA trades at $22.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas UNMA's P/E ratio is 4.59. In terms of profitability, CNO-PA's ROE is +0.10%, compared to UNMA's ROE of +0.07%. Regarding short-term risk, CNO-PA is less volatile compared to UNMA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check UNMA's competition here
CNO-PA vs ATH-PA Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH-PA has a market cap of 4.9B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH-PA trades at $24.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PA's P/E ratio is 3.08. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH-PA's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PA's competition here
CNO-PA vs EQH-PC Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, EQH-PC has a market cap of 4.7B. Regarding current trading prices, CNO-PA is priced at $17.05, while EQH-PC trades at $16.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PC's P/E ratio is 4.21. In terms of profitability, CNO-PA's ROE is +0.10%, compared to EQH-PC's ROE of -2.20%. Regarding short-term risk, CNO-PA and EQH-PC have similar daily volatility (0.00).Check EQH-PC's competition here
CNO-PA vs ATH-PB Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH-PB has a market cap of 3.8B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH-PB trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PB's P/E ratio is 2.37. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH-PB's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PB's competition here
CNO-PA vs ATH-PD Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ATH-PD has a market cap of 3.3B. Regarding current trading prices, CNO-PA is priced at $17.05, while ATH-PD trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PD's P/E ratio is 2.04. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ATH-PD's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ATH-PD's competition here
CNO-PA vs FIHL Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, FIHL has a market cap of 2.4B. Regarding current trading prices, CNO-PA is priced at $17.05, while FIHL trades at $23.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FIHL's P/E ratio is 10.93. In terms of profitability, CNO-PA's ROE is +0.10%, compared to FIHL's ROE of +0.16%. Regarding short-term risk, CNO-PA is less volatile compared to FIHL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FIHL's competition here
CNO-PA vs PLGO Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, PLGO has a market cap of 1.9B. Regarding current trading prices, CNO-PA is priced at $17.05, while PLGO trades at $22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas PLGO's P/E ratio is 6.21. In terms of profitability, CNO-PA's ROE is +0.10%, compared to PLGO's ROE of +0.16%. Regarding short-term risk, CNO-PA is less volatile compared to PLGO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check PLGO's competition here
CNO-PA vs RZC Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, RZC has a market cap of 1.7B. Regarding current trading prices, CNO-PA is priced at $17.05, while RZC trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas RZC's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to RZC's ROE of +0.09%. Regarding short-term risk, CNO-PA is less volatile compared to RZC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check RZC's competition here
CNO-PA vs GSHD Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, GSHD has a market cap of 1.4B. Regarding current trading prices, CNO-PA is priced at $17.05, while GSHD trades at $38.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas GSHD's P/E ratio is 31.51. In terms of profitability, CNO-PA's ROE is +0.10%, compared to GSHD's ROE of -0.30%. Regarding short-term risk, CNO-PA is less volatile compared to GSHD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check GSHD's competition here
CNO-PA vs XZO Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, XZO has a market cap of 1.2B. Regarding current trading prices, CNO-PA is priced at $17.05, while XZO trades at $13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas XZO's P/E ratio is 13.96. In terms of profitability, CNO-PA's ROE is +0.10%, compared to XZO's ROE of +0.42%. Regarding short-term risk, CNO-PA is less volatile compared to XZO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check XZO's competition here
CNO-PA vs IGIC Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, IGIC has a market cap of 1.1B. Regarding current trading prices, CNO-PA is priced at $17.05, while IGIC trades at $25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGIC's P/E ratio is 8.92. In terms of profitability, CNO-PA's ROE is +0.10%, compared to IGIC's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to IGIC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check IGIC's competition here
CNO-PA vs AIZN Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AIZN has a market cap of 939.6M. Regarding current trading prices, CNO-PA is priced at $17.05, while AIZN trades at $18.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIZN's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AIZN's ROE of +0.17%. Regarding short-term risk, CNO-PA is less volatile compared to AIZN. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AIZN's competition here
CNO-PA vs ARGD Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ARGD has a market cap of 874.2M. Regarding current trading prices, CNO-PA is priced at $17.05, while ARGD trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ARGD's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ARGD's ROE of +0.02%. Regarding short-term risk, CNO-PA is less volatile compared to ARGD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ARGD's competition here
CNO-PA vs WDH Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, WDH has a market cap of 508.2M. Regarding current trading prices, CNO-PA is priced at $17.05, while WDH trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WDH's P/E ratio is 6.39. In terms of profitability, CNO-PA's ROE is +0.10%, compared to WDH's ROE of +0.11%. Regarding short-term risk, CNO-PA is less volatile compared to WDH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check WDH's competition here
CNO-PA vs KWY Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, KWY has a market cap of 299M. Regarding current trading prices, CNO-PA is priced at $17.05, while KWY trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas KWY's P/E ratio is -25.82. In terms of profitability, CNO-PA's ROE is +0.10%, compared to KWY's ROE of N/A. Regarding short-term risk, CNO-PA is less volatile compared to KWY. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check KWY's competition here
CNO-PA vs YB Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, YB has a market cap of 111.9M. Regarding current trading prices, CNO-PA is priced at $17.05, while YB trades at $17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas YB's P/E ratio is 3.60. In terms of profitability, CNO-PA's ROE is +0.10%, compared to YB's ROE of +0.66%. Regarding short-term risk, CNO-PA is less volatile compared to YB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check YB's competition here
CNO-PA vs FGFPP Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, FGFPP has a market cap of 25.9M. Regarding current trading prices, CNO-PA is priced at $17.05, while FGFPP trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGFPP's P/E ratio is -7.69. In terms of profitability, CNO-PA's ROE is +0.10%, compared to FGFPP's ROE of -0.72%. Regarding short-term risk, CNO-PA is less volatile compared to FGFPP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check FGFPP's competition here
CNO-PA vs WTREP Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, WTREP has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.05, while WTREP trades at $25.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WTREP's P/E ratio is 1.35. In terms of profitability, CNO-PA's ROE is +0.10%, compared to WTREP's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to WTREP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check WTREP's competition here
CNO-PA vs IGICW Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, IGICW has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.05, while IGICW trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGICW's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to IGICW's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to IGICW. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check IGICW's competition here
CNO-PA vs HGH Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, HGH has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.05, while HGH trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HGH's P/E ratio is -3.09. In terms of profitability, CNO-PA's ROE is +0.10%, compared to HGH's ROE of +0.02%. Regarding short-term risk, CNO-PA and HGH have similar daily volatility (0.00).Check HGH's competition here
CNO-PA vs AMIC Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, AMIC has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.05, while AMIC trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AMIC's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.10%, compared to AMIC's ROE of +0.04%. Regarding short-term risk, CNO-PA is less volatile compared to AMIC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check AMIC's competition here
CNO-PA vs ANAT Comparison June 2026
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 4.6B. In comparison, ANAT has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.05, while ANAT trades at $188.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ANAT's P/E ratio is 6.73. In terms of profitability, CNO-PA's ROE is +0.10%, compared to ANAT's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to ANAT. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.Check ANAT's competition here